$0.168500
-0.0005-0.30%
Last update: 11:42 AM
15 minutes delayed
Comments
Loading...
Qualigen Therapeutics (QLGN) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestQualigen Therapeutics (NASDAQ:QLGN) Stock Quotes, Forecast and News Summary
Qualigen Therapeutics Stock (NASDAQ: QLGN) stock price, news, charts, stock research, profile.
| Open | $0.17 |
| Close | - |
| Volume / Avg. | 62.13K / 11.95M |
| Day Range | $0.16 - $0.17 |
| 52 Wk Range | 0.14 - 1.10 |
| Market Cap | $4.55M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 40 |
| Short Interest | 2.27% |
| Days to Cover | 2.21 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Qualigen Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treat...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Qualigen Therapeutics (QLGN) stock?
You can purchase shares of Qualigen Therapeutics (NASDAQ:QLGN) through any online brokerage.
Who are Qualigen Therapeutics (QLGN) competitors?
Other companies in Qualigen Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Virios Therapeutics (NASDAQ:VIRI), Synaptogenix (NASDAQ:SNPX), Palisade Bio (NASDAQ:PALI) and AquaBounty Techs (NASDAQ:AQB).
What is the forecast, or price target, for Qualigen Therapeutics (QLGN) stock?
There is no analysis for Qualigen Therapeutics to provide a consensus price target.
What is the current price for Qualigen Therapeutics (QLGN)?
The stock price for Qualigen Therapeutics (NASDAQ: QLGN) is $0.1685 last updated September 23, 2024 at 11:42 AM EDT.
Does Qualigen Therapeutics (QLGN) pay a dividend?
There are no upcoming dividends for Qualigen Therapeutics.
When is Qualigen Therapeutics (NASDAQ:QLGN) reporting earnings?
Qualigen Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Qualigen Therapeutics (QLGN) going to split?
There is no upcoming split for Qualigen Therapeutics.
What sector and industry does Qualigen Therapeutics (QLGN) operate in?
Qualigen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.